Verónica Martínez Cerdeño1,2,3, Tiffany Hong1,2, Sarwat Amina2,3, Mirna Lechpammer1, Jeanelle Ariza1,2, Flora Tassone3,4, Stephen C Noctor3,5, Paul Hagerman3,4, Randi Hagerman3,6. 1. Department of Pathology and Laboratory Medicine, UC Davis School of Medicine, Sacramento, California, USA. 2. Institute for Pediatric Regenerative Medicine and Shriners Hospitals for Children of Northern California, Sacramento, California, USA. 3. MIND Institute, UC Davis Medical Center, Sacramento, California, USA. 4. Department of Biochemistry and Molecular Medicine, UC Davis School of Medicine Sacramento, California, USA. 5. Department of Psychiatry and Behavioral Sciences, UC Davis School of Medicine Sacramento, California, USA. 6. Department of Pediatrics, UC Davis School of Medicine Sacramento, California, USA.
Abstract
BACKGROUND: Fragile X-associated tremor/ataxia syndrome (FXTAS) is a late-onset neurodegenerative disorder associated with premutation alleles of the FMR1 gene. Expansions of more than 200 CGG repeats give rise to fragile X syndrome, the most common inherited form of cognitive impairment. Fragile X-associated tremor/ataxia syndrome is characterized by cerebellar tremor and ataxia, and the presence of ubiquitin-positive inclusions in neurons and astrocytes. It has been previously suggested that fragile X-associated tremor/ataxia syndrome is associated with an inflammatory state based on signs of oxidative stress-mediated damage and iron deposition. OBJECTIVE: Determine whether the pathology of fragile X-associated tremor/ataxia syndrome involves microglial activation and an inflammatory state. METHODS: Using ionized calcium binding adaptor molecule 1 and cluster differentiation 68 antibodies to label microglia, we examined the number and state of activation of microglial cells in the putamen of 13 fragile X-associated tremor/ataxia syndrome and 9 control postmortem cases. RESULTS: Nearly half of fragile X-associated tremor/ataxia syndrome cases (6 of 13) presented with dystrophic senescent microglial cells. In the remaining fragile X-associated tremor/ataxia syndrome cases (7 of 13), the number of microglial cells and their activation state were increased compared to controls. CONCLUSIONS: The presence of senescent microglial cells in half of fragile X-associated tremor/ataxia syndrome cases suggests that this indicator could be used, together with the presence of intranuclear inclusions and the presence of iron deposits, as a biomarker to aid in the postmortem diagnosis of fragile X-associated tremor/ataxia syndrome. An increased number and activation indicate that microglial cells play a role in the inflammatory state present in the fragile X-associated tremor/ataxia syndrome brain. Anti-inflammatory treatment of patients with fragile X-associated tremor/ataxia syndrome may be indicated to slow neurodegeneration.
BACKGROUND:Fragile X-associated tremor/ataxia syndrome (FXTAS) is a late-onset neurodegenerative disorder associated with premutation alleles of the FMR1 gene. Expansions of more than 200 CGG repeats give rise to fragile X syndrome, the most common inherited form of cognitive impairment. Fragile X-associated tremor/ataxia syndrome is characterized by cerebellar tremor and ataxia, and the presence of ubiquitin-positive inclusions in neurons and astrocytes. It has been previously suggested that fragile X-associated tremor/ataxia syndrome is associated with an inflammatory state based on signs of oxidative stress-mediated damage and iron deposition. OBJECTIVE: Determine whether the pathology of fragile X-associated tremor/ataxia syndrome involves microglial activation and an inflammatory state. METHODS: Using ionized calcium binding adaptor molecule 1 and cluster differentiation 68 antibodies to label microglia, we examined the number and state of activation of microglial cells in the putamen of 13 fragile X-associated tremor/ataxia syndrome and 9 control postmortem cases. RESULTS: Nearly half of fragile X-associated tremor/ataxia syndrome cases (6 of 13) presented with dystrophic senescent microglial cells. In the remaining fragile X-associated tremor/ataxia syndrome cases (7 of 13), the number of microglial cells and their activation state were increased compared to controls. CONCLUSIONS: The presence of senescent microglial cells in half of fragile X-associated tremor/ataxia syndrome cases suggests that this indicator could be used, together with the presence of intranuclear inclusions and the presence of iron deposits, as a biomarker to aid in the postmortem diagnosis of fragile X-associated tremor/ataxia syndrome. An increased number and activation indicate that microglial cells play a role in the inflammatory state present in the fragile X-associated tremor/ataxia syndrome brain. Anti-inflammatory treatment of patients with fragile X-associated tremor/ataxia syndrome may be indicated to slow neurodegeneration.
Authors: J R Brouwer; E J Mientjes; C E Bakker; I M Nieuwenhuizen; L A Severijnen; H C Van der Linde; D L Nelson; B A Oostra; R Willemsen Journal: Exp Cell Res Date: 2006-10-13 Impact factor: 3.905
Authors: Claudia M Greco; Flora Tassone; Dolores Garcia-Arocena; Nicole Tartaglia; Sarah M Coffey; Timothy K Vartanian; James A Brunberg; Paul J Hagerman; Randi J Hagerman Journal: Arch Neurol Date: 2008-08
Authors: Peter K Todd; Seok Yoon Oh; Amy Krans; Fang He; Chantal Sellier; Michelle Frazer; Abigail J Renoux; Kai-chun Chen; K Matthew Scaglione; Venkatesha Basrur; Kojo Elenitoba-Johnson; Jean P Vonsattel; Elan D Louis; Michael A Sutton; J Paul Taylor; Ryan E Mills; Nicholas Charlet-Berguerand; Henry L Paulson Journal: Neuron Date: 2013-04-18 Impact factor: 17.173
Authors: Rahul A Jonas; Ti-Fei Yuan; Yu-Xiang Liang; Jost B Jonas; David K C Tay; Rutledge G Ellis-Behnke Journal: PLoS One Date: 2012-02-21 Impact factor: 3.240
Authors: Alice F Tarantal; Dennis J Hartigan-O'Connor; Elisa Penna; Anna Kreutz; Michele L Martinez; Stephen C Noctor Journal: Cereb Cortex Date: 2021-03-31 Impact factor: 5.357
Authors: Katharine Nichole Holm; Anthony W Herren; Sandra L Taylor; Jamie L Randol; Kyoungmi Kim; Glenda Espinal; Verónica Martiínez-Cerdeño; Isaac N Pessah; Randi J Hagerman; Paul J Hagerman Journal: Front Mol Biosci Date: 2021-01-29
Authors: Kevin Sanchez; Jeffrey S Darling; Reha Kakkar; Sienna L Wu; Andrew Zentay; Christopher A Lowry; Laura K Fonken Journal: Sci Rep Date: 2022-02-09 Impact factor: 4.379